New Delhi: The initial public offer of Akums Drugs and Pharmaceuticals got fully ..nnNew Delhi: The initial public offer of Akums Drugs and Pharmaceuticals got fully .. nnRead more at: nhttps://health.economictimes.indiatimes.com/news/pharma/financial-performance/akums-drugs-and-pharmaceuticals-ipo-gets-fully-subscribed-on-day-1-of-offer/112156903?utm_source=top_news&utm_medium=sectionListing
Akums unveils new formulations for Gastrointestinal patients in India
Akums introduces Hydroxyurea oral suspension for sickle cell disease
Akums launches generic formulation to treat migraine
Akums gets DCGI nod for triple combination diabetes medication
This approval allows Perampanel Oral Suspension to serve as adjunctive therapy for treatment of partial-onset seizures (POS) with or without secondarily generalised seizures, as well as primary generalised tonic-clonic (PGTC) seizures in patients with epilepsy aged 12 years and older
Akums Drugs & Pharmaceuticals on Thursday said it has forayed into the gummies segment by setting up a new manufacturing plant. The company said it aims to cater to a host of conditions for adults, paediatrics and geriatric population who are looking for an alternative to conventional dosage forms like tablets, capsules, syrup etc, who no longer find these options palatable or convenient.
Akums, Lyrus Life Sciences collaborate for patented technologies and formulations
Akums receives DCGI approval for type 2 diabetes drug to improve insulin resistance